About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Extended Salford Lung Study ("Ex-SLS") Data Access Project

NCT03152669·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Subjects who were randomized to treatment in the original SLS studies
Subjects who are able to, and choose to, provide written consent for the additional information to be collected.

You may not be if

Subjects who were lost to follow-up/moved away, withdrew consent or died during or subsequent to the original SLS studies.
Subjects considered (at the discretion of the investigator) as too ill to participate or without the mental capacity to provide informed consent.

The record

StatusCompleted

PhaseNo phase

Taking part1,183

StartedApr 2018

UpdatedJul 7, 2026

Conditions

Where1

GSK Investigational Site
Manchester, United Kingdom

Clareo Health | The Extended Salford Lung Study ("Ex-SLS") Data Access Project